🔗 Permalink

Assignee profile:

BrainCells Inc.

City:

San Diego, California

Country:

United States

Published Applications:

Last publication date:

2011-12-29

Patent Grants:

Last grant date:

2010-12-28

Top Inventors for applications by BrainCells Inc.

These are the the leading inventors for applications assigned to BrainCells Inc.:

Kai Treuner 27 San Diego, CA United States
Carrolee BARLOW 24 Del Mar, CA United States
Kym I. Lorrain 23 San Diego, CA United States
Todd A. Carter 22 San Diego, CA United States

Andrew Morse 21 San Diego, CA United States
Jammieson C. Pires 8 San Diego, CA United States
Dana Gitnick 5 San Marcos, CA United States
Todd Carter 5 San Diego, CA United States

Kym Lorrain 3 San Diego, CA United States
Carrolee BARLOW 2 Solana Beach, CA United States
Alex Broadhead 2 San Diego, CA United States
Carolee BARLOW 2 Del Mar, CA United States

Jeff Redwine 2 San Diego, CA United States
Christine Hoffmaster 1 El Cajon, CA United States
Tood A. Carter 1 San Diego, CA United States
Michael Lee 1 San Diego, CA United States

Corey R. Seehus 1 San Diego, CA United States
Alejandro R. Dearie 1 Chula Vista, CA United States
Jammieson Pires 1 Chula Vista, CA United States
Christine Hoffmaster 1 Lakeside, CA United States

Recent patent applications by BrainCells Inc.

BrainCells Inc. based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-12-29

US20110319386A1

Human necessities

NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION

#2 | 2011-11-03

US20110269717A1

Human necessities

NEUROGENESIS BY MODULATING ANGIOTENSIN

#3 | 2011-04-21

US20110092464A1

Human necessities

NEUROGENESIS BY MODULATING ANGIOTENSIN

#4 | 2011-02-24

US20110046090A1

Human necessities

MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS

#5 | 2010-08-26

US20100216805A1

Human necessities

MODULATION OF NEUROGENESIS USING D-CYCLOSERINE COMBINATIONS

#6 | 2010-08-26

US20100216734A1

Human necessities

MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS

#7 | 2010-07-22

US20100184806A1

Human necessities

MODULATION OF NEUROGENESIS BY PPAR AGENTS

#8 | 2010-05-13

US20100120842A1

Human necessities

NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION

#9 | 2010-01-14

US20100009983A1

Human necessities

5 HT RECEPTOR MEDIATED NEUROGENESIS

#10 | 2009-12-31

US20090325949A1

Human necessities

5 HT RECEPTOR MEDIATED NEUROGENESIS

#11 | 2009-09-24

US20090239834A1

Human necessities

MCC-257 MODULATION OF NEUROGENESIS

#12 | 2009-08-06

US20090197823A1

Human necessities

ALISKIREN MODULATION OF NEUROGENESIS

#13 | 2008-08-07

US20080188457A1

Human necessities

Modulation of Neurogenesis with Biguanides and GSK3-beta Agents

#14 | 2008-07-17

US20080171750A1

Human necessities

Modulation Of Neurogenesis With Use of Modafinil

#15 | 2008-07-10

US20080167363A1

Human necessities

Modulation of Neurogenesis By Melatoninergic Agents

#16 | 2008-07-10 ✅ Patent 7,858,611 granted on 2010-12-28

US20080167291A1

Human necessities

Neurogenesis by modulating angiotensin

#17 | 2008-05-08

US20080108574A1

Human necessities

MELANOCORTIN RECEPTOR MEDIATED MODULATION OF NEUROGENESIS

#18 | 2008-05-01

US20080103165A1

Human necessities

PPAR MEDIATED MODULATION OF NEUROGENESIS

#19 | 2008-05-01

US20080103105A1

Human necessities

HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS

#20 | 2008-03-13 ✅ Patent 7,998,971 granted on 2011-08-16

US20080064671A1

Human necessities

Combinations containing a 4-acylaminopyridine derivative

#21 | 2007-11-22 ✅ Patent 7,678,808 granted on 2010-03-16

US20070270449A1

Human necessities

5 HT receptor mediated neurogenesis

#22 | 2007-10-18

US20070244143A1

Human necessities

MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS

#23 | 2007-09-06 ✅ Patent 7,985,756 granted on 2011-07-26

US20070208029A1

Human necessities

Modulation of neurogenesis by PDE inhibition

#24 | 2007-05-17

US20070112017A1

Human necessities

GABA RECEPTOR MEDIATED MODULATION OF NEUROGENESIS

#25 | 2007-04-05

US20070078083A1

Human necessities

MODULATION OF NEUORGENESIS BY HDac INHIBITION

#26 | 2007-03-01 ✅ Patent 7,678,363 granted on 2010-03-16

US20070049576A1

Human necessities

Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs

#27 | 2007-01-18

US20070015138A1

Physics

Methods for identifying agents and conditions that modulate neurogenesis

AssigneeID:

198053 ⎘